A Critical Evaluation of Nigeria's Response to the First Wave of COVID-19

Overview

Journal Bull Natl Res Cent

Date 2022 Mar 1

PMID 35228791

Authors

Ezekiel Damilare Jacobs

Malachy Ifeanyi Okeke

Affiliations

Soon will be listed here.

Abstract

Background: The first wave of the Coronavirus Disease 2019 (COVID-19) pandemic began when the first index case was reported in Nigeria on the 27th of February 2020, and since then, more than 68,000 cases of the disease were confirmed, with 1173 deaths as of November 30, 2020.

Main Body: Daily situation reports from the Nigeria Centre for Disease Control spanning February 27-November 30, 2020, were fully considered in this review. Further literature search was performed using PubMed and Google Scholar databases for articles related to response measures adopted by Nigeria. The instantaneous reproduction number () was then estimated as a metric to investigate the non-pharmaceutical intervention measures. Nigeria responded to COVID-19 pandemic by implementing anti-COVID-19 mitigation strategies in travel restrictions, social distancing, source control, contact tracing, self-isolation, and quarantine, as well as in clinical interventions. Our epidemiological model estimated the -value of more than 1.0 in Nigeria and in each of all the 36 states and the Federal Capital Territory.

Conclusion: Nigeria implemented containment and mitigation measures in response to the first wave of COVID-19 and these measures may have contributed to the mild COVID-19 outcome in Nigeria compared to the global trend. However, inadequate PCR testing capacity, lack or suboptimal utilization of epidemic metrics like the virus reproduction number () to inform decision making, and premature easing of lockdown measures among others were major challenges to the effective implementation of the COVID-19 response measures.

Citing Articles

Spaces of Exclusion and Neglect: The Impact of COVID-19 on People With Disabilities in Bangladesh, Kenya, Nepal, Nigeria, and Uganda.

Thompson S, Rohwerder B Space Cult. 2024; 26(3):451-467.

PMID: 38603319 PMC: 9996068. DOI: 10.1177/12063312231159208.

SARS-CoV-2 incidence monitoring and statistical estimation of the basic and time-varying reproduction number at the early onset of the pandemic in 45 sub-Saharan African countries.

Oduro M, Arhin-Donkor S, Asiedu L, Kadengye D, Iddi S BMC Public Health. 2024; 24(1):612.

PMID: 38409118 PMC: 10895859. DOI: 10.1186/s12889-024-18184-8.

Train-the-trainers intervention for national capacity building in infection prevention and control for COVID-19 in Nigeria.

Shehu N, Okwor T, Dooga J, Wele A, Cihambanya L, Okonkon I Heliyon. 2023; 9(11):e21978.

PMID: 38034678 PMC: 10682610. DOI: 10.1016/j.heliyon.2023.e21978.

Fraud within the Nigerian health system, a double threat for resilience of a health system and the response to the COVID-19 pandemic: a review.

Akokuwebe M, Idemudia E Pan Afr Med J. 2023; 45:116.

PMID: 37745915 PMC: 10516760. DOI: 10.11604/pamj.2023.45.116.36979.

National and subnational governance and decision-making processes during the COVID-19 pandemic in Nigeria: an empirical analysis.

Mukherjee S, Asthana S, Ukponu W, Ihueze A, Gobir I, Phelan A BMJ Glob Health. 2023; 8(9).

PMID: 37696545 PMC: 10496651. DOI: 10.1136/bmjgh-2023-012965.

References

Abubakar I, Dalglish S, Ihekweazu C, Bolu O, Aliyu S . Lessons from co-production of evidence and policy in Nigeria's COVID-19 response. BMJ Glob Health. 2021; 6(3). PMC: 7985933. DOI: 10.1136/bmjgh-2020-004793. View

Okuonghae D, Omame A . Analysis of a mathematical model for COVID-19 population dynamics in Lagos, Nigeria. Chaos Solitons Fractals. 2020; 139:110032. PMC: 7305939. DOI: 10.1016/j.chaos.2020.110032. View

Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa F, Corcione S . 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020; 21:22-27. PMC: 7102618. DOI: 10.1016/j.jgar.2020.02.021. View

Du Z, Xu X, Wu Y, Wang L, Cowling B, Meyers L . Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerg Infect Dis. 2020; 26(6):1341-1343. PMC: 7258488. DOI: 10.3201/eid2606.200357. View

Ogunbameru A, Barrett K, Joda A, Khan Y, Pechlivanoglou P, Mac S . Estimating healthcare resource needs for COVID-19 patients in Nigeria. Pan Afr Med J. 2021; 37:293. PMC: 7881931. DOI: 10.11604/pamj.2020.37.293.26017. View

Rabi F, Zoubi M, Kasasbeh G, Salameh D, Al-Nasser A . SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens. 2020; 9(3). PMC: 7157541. DOI: 10.3390/pathogens9030231. View

Adam D . A guide to R - the pandemic's misunderstood metric. Nature. 2020; 583(7816):346-348. DOI: 10.1038/d41586-020-02009-w. View

Flaxman S, Mishra S, Gandy A, Unwin H, Mellan T, Coupland H . Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020; 584(7820):257-261. DOI: 10.1038/s41586-020-2405-7. View

Adams J, MacKenzie M, Amegah A, Ezeh A, Gadanya M, Omigbodun A . The Conundrum of Low COVID-19 Mortality Burden in sub-Saharan Africa: Myth or Reality?. Glob Health Sci Pract. 2021; 9(3):433-443. PMC: 8514030. DOI: 10.9745/GHSP-D-21-00172. View

10.

Aiyewumi O, Okeke M . The myth that Nigerians are immune to SARS-CoV-2 and that COVID-19 is a hoax are putting lives at risk. J Glob Health. 2020; 10(2):020375. PMC: 7568914. DOI: 10.7189/jogh.10.020375. View

11.

Onyeaghala A, Olajide I . Managing COVID-19 outbreak in Nigeria: matters arising. Clin Chem Lab Med. 2020; 58(10):1645-1650. DOI: 10.1515/cclm-2020-0748. View

12.

Cyranoski D . Profile of a killer: the complex biology powering the coronavirus pandemic. Nature. 2020; 581(7806):22-26. DOI: 10.1038/d41586-020-01315-7. View

13.

Ibrahim R, Ajide K, Olatunde Julius O . Easing of lockdown measures in Nigeria: Implications for the healthcare system. Health Policy Technol. 2020; 9(4):399-404. PMC: 7490626. DOI: 10.1016/j.hlpt.2020.09.004. View

14.

Moodley K, Obasa A, London L . Isolation and quarantine in South Africa during COVID-19: Draconian measures or proportional response?. S Afr Med J. 2020; 110(6):456-457. DOI: 10.7196/SAMJ.2020v110i6.14842. View

15.

Di Nardo M, van Leeuwen G, Loreti A, Barbieri M, Guner Y, Locatelli F . A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children. Pediatr Res. 2020; 89(5):1101-1108. DOI: 10.1038/s41390-020-1065-5. View

16.

Wang L, Wang Y, Ye D, Liu Q . Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020; 55(6):105948. PMC: 7156162. DOI: 10.1016/j.ijantimicag.2020.105948. View

17.

Balmford B, Annan J, Hargreaves J, Altoe M, Bateman I . Cross-Country Comparisons of Covid-19: Policy, Politics and the Price of Life. Environ Resour Econ (Dordr). 2020; 76(4):525-551. PMC: 7400753. DOI: 10.1007/s10640-020-00466-5. View

18.

Dan-Nwafor C, Ochu C, Elimian K, Oladejo J, Ilori E, Umeokonkwo C . Nigeria's public health response to the COVID-19 pandemic: January to May 2020. J Glob Health. 2020; 10(2):020399. PMC: 7696244. DOI: 10.7189/jogh.10.020399. View

19.

Cori A, Ferguson N, Fraser C, Cauchemez S . A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol. 2013; 178(9):1505-12. PMC: 3816335. DOI: 10.1093/aje/kwt133. View

20.

Wang C, Ng C, Brook R . Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. JAMA. 2020; 323(14):1341-1342. DOI: 10.1001/jama.2020.3151. View